Blasco I, Schmitt TL, Steiner E, Trieb K, Grubeck-Loebenstein B. 1997.
Tumor necrosis factor augments amyloid protein (25–35) induced
apoptosis in human cells. Neurosci Lett 238:17–20.
Bradford MM. 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein using the principle of protein binding.
Anal Biochem 72:248 –254.
Bruce AJ, Boling W, Kindy MS, Reschon J, Kraemer PJ, Carpenter MK,
Holtsberg FW, Mattson MP. 1996. Altered neuronal and microglial
responses to excitotoxic and ischemic brain injury in mice lacking TNF
receptors. Nat Med 2:788 –794.
Busciglio J, Lorenzo A, Yankner BA. 1992. Methodological variables in the
assessment of beta amyloid neurotoxicity. Neurobiol Aging 13:609 – 612.
Butterfield DA, Koppal T, Subramaniam R, Yatin S. 1999. Vitamin E as an
antioxidant/free radical scavenger against amyloid beta-peptide-induced
oxidative stress in neocortical synaptosomal membranes and hippocampal
neurones in culture: insights into Alzheimer's disease. Rev Neurosci
10:141–149.
Cardoso SM, Swerdlow RH, Oliveira CR. 2002. Induction of cytochrome
c-mediated apoptosis by amyloid 25–35 requires functional mitochondria. Brain Res 931:117–125.
Chao CC, Hu S. 1994. Tumor necrosis factor-alpha potentiates glutamate
neurotoxicity in human fetal brain cultures. Dev Neurosci 16:172–179.
Delobette S, Privat A, Maurice T. 1997. In vitro aggregation facilities
beta-amyloid peptide-(25–35)-induced amnesia in the rat. Eur J Pharmacol 319:1– 4.
DiCarlo G, Wilcock D, Henderson D, Gordon M, Morgan D. 2001.
Intrahippocampal LPS injections reduce A load in APP PS1 transgenic
mice. Neurobiol Aging 22:1007–1012.
Emre M, Geula C, Ransil BJ, Mesulam MM. 1992. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected
-amyloid in the rat brain. Neurobiol Aging 13:553–559.
Feuerstein G, Wang X, Barone FC. 1998. Cytokines in brain ischemia—
the role of TNF . Cell Mol Neurobiol 18:695–701.
Fontaine V, Mohand-Said S., Hanoteau N, Fuchs C, Pfizenmaier K, Eisel
U. 2002. Neurodegenerative and neuroprotective effects of tumor ne- crosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1
and TNF receptor 2. J Neurosci 22:1–7.
Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE,
Capaccioli S, Orlandini SZ. 2000. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis
and necrosis. J Cell Physiol 182:41– 49.
Gathan E, Overmeier JB. 1999. Inflammatory pathogenesis in Alzheimer's
disease: biological mechanisms and cognitive sequeli. Neurosci Biobehav
Rev 23:615– 633.
Giovannelli L, Casamenti F, Scali C, Bartolini L, Pepeu G. 1995. Differential effects of amyloid peptides -(1– 40) and -(25–35) injections into
the rat nucleus basalis. Neuroscience 66:781–792.
Glabinski A, Krajewski S, Rafalowska J. 1998. Tumor necrosis factorinduced pathology in the rat brain: characterization of stereotaxic injection model. Folia Neuropathol 36:52– 62.
Harkany T, Mulder J, Sasvan M, Abraham I, Konya C, Zarandi M, Penke
B, Luiten PGM, Nyakas C. 1999. N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis
neurons against -amyloid neurotoxicity. Neurobiol Dis 6:109 –121.
Hsu H, Xiong J, Goeddel DV. 1995. The TNF receptor 1-associated
protein TRADD signals cell death and NF-kB activation. Cell 81:495–
504.
Hsu H, Shu H-B, Pan M-G, Goeddel DV. 1996. TRADD-TRAF2 and
TRADD-FADD interactions define two distinct TNF receptor signal
transduction pathways. Cell 84:299 –308.
Ivins KJ, Ivins JK, Sharp J, Cotman CW. 1999. Multiple pathways of
apoptosis in PC12 cells. CrmA inhibits apoptosis induced by -amyloid.
J Biol Chem. 274:2107–2112.
Kassiotis G, Kollias G. 2001. Uncoupling the proinflammatory from the
